Cargando…
Head and neck cancer care in the COVID-19 pandemic: A brief update
Autores principales: | Yuen, Erick, Fote, Gianna, Horwich, Peter, Nguyen, Shaun A., Patel, Rusha, Davies, Joel, Houlton, Jeffrey, Nathan, Cherie-Ann, St. John, Maie, Day, Terry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177064/ https://www.ncbi.nlm.nih.gov/pubmed/32345570 http://dx.doi.org/10.1016/j.oraloncology.2020.104738 |
Ejemplares similares
-
mTOR inhibitor use in head and neck squamous cell carcinoma: A meta‐analysis on survival, tumor response, and toxicity
por: Patel, Jaimin, et al.
Publicado: (2020) -
Predictors of Nodal Metastasis in Cutaneous Head and Neck Cancers
por: Han, Albert Y., et al.
Publicado: (2022) -
Regional pedicled flap salvage options for large head and neck defects: The old, the new, and the forgotten
por: Chang, Brent A., et al.
Publicado: (2022) -
Concerns and Needs of Patients With Head and Neck Cancer in the COVID-19 Era
por: Yan, Flora, et al.
Publicado: (2021) -
Head and neck cancer survivorship consensus statement from the American Head and Neck Society
por: Goyal, Neerav, et al.
Publicado: (2021)